Blueprint Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Blueprint Investment Partners's LLY Position: Q1 2025 in Review
Blueprint Investment Partners sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 4,590 shares — an estimated $3.54M sold.
Blueprint Investment Partners first reported a position in LLY in Q3 2021 and held it in 14 quarters. The position peaked at $4.36M in Q3 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.
- Blueprint Investment Partners reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
- Blueprint Investment Partners sold 4,590 Eli Lilly shares in Q1 2025, an estimated $3.54M.
- Blueprint Investment Partners first reported a position in Eli Lilly in Q3 2021 and held it in 14 quarters.
- Blueprint Investment Partners's Eli Lilly position peaked at $4.36M in Q3 2024.
- 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.
Based on Blueprint Investment Partners's 13F filing for Q1 2025, filed 12 May 2025.